Skip to content
Biobased products significantly cut down the consumption of fossil fuels and play a pivotal role in the U.S. economy, according to a recent report […]
Biobased products have positive impact on environment, economy, says USDA report Read More »
Hemp genetically modified to remove the two better-known cannabinoids joined several other plants in gaining U.S. Department of Agriculture (USDA) regulatory clearance so that
Bioengineered hemp with reduced THC and CBD wins regulatory clearance Read More »
Sharon King’s daughter Taylor was a happy surprise. And up until Taylor was in the first grade, she was developing normally. But the first
Bespoke Gene Therapy Consortium gives rare disease biotechs a path forward Read More »
Artificial intelligence (AI) is revolutionizing drug discovery, paving the way for groundbreaking treatments. In fact, a recent study found that biotech companies using AI
How does AI drug discovery really work? A new paper reveals the process Read More »
A year ago, the sentiment for the industry was extremely low. In 2023, the biotech stock indices were sliding to potential new lows, levels
5 reasons for investor optimism at BIO-Europe Spring 2024 Read More »
Almost 66% of U.S. households are home to pets—mainly dogs and cats, but also other animals. As most pet owners refer to them as
How biotech is improving the health of our pets Read More »
Editor’s Note: On Wednesday, May 1, 2024, the California Supreme Court said it will consider Gilead’s request for summary dismissal, agreeing with BIO’s March
BIO opposes lawsuit that would penalize drugmaker for innovating too slowly Read More »
The Biotechnology Innovation Organization (BIO) is hosting the first-ever BIO Agriculture & Environment Summit on April 17-18, 2024, a chance to discuss the role
BIO announces first-ever Agriculture & Environment Summit Read More »
A strong bioeconomy can help us mitigate climate change, increase sustainable production, and expand manufacturing of cutting-edge therapies while boosting U.S. technological capabilities and
What it takes to achieve ‘bold goals’ for the U.S. bioeconomy Read More »
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments.
Heart disease patients and the IRA’s misguided incentives Read More »
